Botulinum toxin and idiopathic dentoalveolar pain

Botulinum toxin

This review of the use of botulinum toxin (BONT-A) for pain-relief in patients with persistent idiopathic dentoalveolar pain included just 3 small uncontrolled studies providing a very limited amounh of very low quality evidence.

[read the full story...]

Little good evidence currently available to support the effectiveness of antidepressants in the treatment of orofacial pain

shutterstock_7431811

Orofacial pain is a relatively common and is categorized into musculoskeletal; neuropathic; vascular; neurovascular; idiopathic; pain caused by local, distant, or systemic pathology; and psychogenic.  Diagnosis can be challenging when psychosocial factors are present and while antidepressants have been used as a treatment there remains some controversy.  The aim of this review was to assess [read the full story…]